Neurotez, Inc.

Neurotez, Inc. Neurotez is a private corporation developing a human Leptin product as a hormone replacement therapy for Alzheimer's disease.

https://www.linkedin.com/feed/update/urn:li:activity:7396916946669109248/
11/20/2025

https://www.linkedin.com/feed/update/urn:li:activity:7396916946669109248/

We are pleased to welcome Nikolaos Tezapsidis, President & CEO of Neurotez, Inc., as the Day 2 Chairperson for the ๐Ÿฎ๐Ÿฐ๐˜๐—ต ๐—•๐—ถ๐—ผ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ ๐——๐—ฟ๐˜‚๐—ด ๐——๐—ถ๐˜€๐—ฐ๐—ผ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ก๐—ฒ๐˜…๐˜‚๐˜€ ๐—ก๐—ฒ๐˜„ ๐—๐—ฒ๐—ฟ๐˜€๐—ฒ๐˜† Dr. Tezapsidis, an...

https://www.facebook.com/share/p/15Cat97iK5/
03/28/2025

https://www.facebook.com/share/p/15Cat97iK5/

Amidst the deluge of data, finding the right balance between working models and useful insights remains pivotal in forging the path towards leveraging computational success in the field of biotech and pharma.

Last Tuesday's Drug Discovery Biology & Bioinformatics Strategy Meeting in Princeton buzzed with a critical discussion o...
05/18/2024

Last Tuesday's Drug Discovery Biology & Bioinformatics Strategy Meeting in Princeton buzzed with a critical discussion on financing blueprints for your next breakthrough!

VC expert Gunaretnam (Guna) Rajagopal of Samsara BioCapital, expertly guided our high-powered panel: Christopher Conway (Curia), President of Research and Development, Marcie Glicksman (EnClear Therapies), VP Biology, and myself, Nikolaos Tezapsidis (Neurotez, Inc.), President & CEO

From go-to-clinic to go-to-market and go-to-fundraising strategies, the panel dissected the pros and cons of various financing blueprints, offering invaluable insights for attendees.

Missed the session? Stay tuned for more event highlights! hashtag hashtag hashtag hashtag

From our partners at Cytox:  Should everyone know their personal risk of developing Alzheimer's disease?
12/16/2022

From our partners at Cytox:

Should everyone know their personal risk of developing Alzheimer's disease?

Over the last few days there have been two big stories in the news concerning Alzheimerโ€™s disease, a devastating brain disorder that destroys memory and the ability to perform simple tasks. The first came from Thor himself, actor Chris Hemsworth, who revealed he has two copies of the APOE4 gene, w...

We just launched:
09/01/2022

We just launched:

Neurotez Inc. is developing a drug to treat Leptin deficiency and cognitive decline in Alzheimerโ€™s disease patients.

Neurotez's offering ends soon! Don't miss your opportunity to become an investor in a biotechnology company that gives A...
02/11/2022

Neurotez's offering ends soon! Don't miss your opportunity to become an investor in a biotechnology company that gives Alzheimerโ€™s patients access to novel therapies. Secure your investment today!

Innovative Solutions for Brain Disorders

JOIN US FOR THIS GREAT EVENThttps://biotechplanet.net/  presenting
12/12/2021

JOIN US FOR THIS GREAT EVENT

https://biotechplanet.net/

presenting

At BIOTECH PLANET you find a global group of like-minded people, and future partners, with new perspectives to improve our current standards.

Address

111 Tower Square Place, Suite 1201
Jersey City, NJ
07310

Alerts

Be the first to know and let us send you an email when Neurotez, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Neurotez, Inc.:

Share